Metal Complex Immobilization for Oriented Biomolecule Binding

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for immobilizing biomolecules like peptides and proteins on solid supports are limited by selectivity issues, reproducibility problems, and require pre-modification or use of expensive reagents, leading to unstable binding and potential damage to the target molecule.

Innovation Solution

A method involving the use of unmodified target molecules and metal complexes to form stable coordination bonds with a substrate, allowing for tunable binding strength and orientation without the need for pre-modification or multiple chemistry steps.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Strength

If covalent coupling methods (amide formation, thioether formation, disulfide formation, imine formation) are used to immobilize biomolecules, then the binding strength is improved, but the selectivity deteriorates and the biomolecules are bound in random orientations

Engineering Contradiction:
Improvebinding strengthVSAvoidorientation control
Core Design Contradiction:
StrengthVSManufacturing precision

Solution Approach 1:

The patent introduces a metal complex as an intermediary between the solid support and the biomolecule. The metal complex contains a chelating group attached to the solid support and a coordination site that specifically binds to a cysteine residue on the biomolecule. This intermediary enables oriented immobilization while maintaining strong binding, resolving the contradiction between binding strength and orientation control.

Inventive Principle:
Principle #24Intermediary (Mediator)

2Strength

If high affinity binding interactions (biotin-avidin/strepavidin) are used, then the binding strength is improved, but the device complexity increases due to the need for fusion tags

Engineering Contradiction:
Improvebinding strengthVSAvoidfusion tag requirement
Core Design Contradiction:
StrengthVSDevice complexity

Solution Approach 1:

The patent extracts the cysteine residue from the context of requiring entire fusion tags (like biotin or polyhistidine tags). By designing the metal complex to specifically coordinate with the sulfur atom in cysteine residues that are naturally present or easily introduced at specific sites in proteins, the method achieves high affinity binding without the need for large, complex fusion tags, thereby reducing device complexity while maintaining binding strength.

Inventive Principle:
Principle #2Taking out (Extraction)

3Device complexity

If metal ions are immobilised through metal chelating groups (IMAC) without polyHis tags, then the device complexity is reduced, but the binding strength becomes unpredictable and reproducibility deteriorates

Engineering Contradiction:
Improvetag requirementVSAvoidreproducibility
Core Design Contradiction:
Device complexityVSReliability

Solution Approach 1:

The patent systematically optimizes multiple parameters of the metal complex including the choice of metal ion (transition metals with appropriate coordination chemistry), the chelating group structure (to control geometry and stability), and the linker between the chelating group and solid support. These controlled parameter changes create a standardized platform that delivers reproducible, predictable binding strength without requiring polyHis tags, thus improving reliability while maintaining low device complexity.

Inventive Principle:
Principle #35Parameter changes

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This approach provides a robust and reproducible method for immobilizing target molecules, maintaining their functional conformation and orientation, and enabling efficient binding with complementary molecules across a broad range of conditions.

Implementation Method 1

the target molecule is bound to the metal in the metal complex through a coordination bond

Methodology Applied
Scientific EffectCoordination bonding: Chemical Bonding

Data Source

PatentUS9234891B2Use of metal complexes
Publication Date: 2016.01.12 ANTEO TECHNOLOGIES PTY LTD
  • US9234891B2 patent drawing
  • US9234891B2 patent drawing
  • US9234891B2 patent drawing

AI summary

A method of immobilizing a target molecule on a substrate, which comprises exposing the target molecule to the substrate in the presence of a metal complex, wherein the target molecule is an unmodified target molecule, and wherein the metal complex is selected to provide a stable binding interaction between the target molecule and the substrate.